Publications by authors named "A Konyi"
Article Synopsis
- The QLV ratio is an important measurement during cardiac resynchronization therapy (CRT) that helps predict how effective the treatment will be.
- A new technique called left bundle branch area pacing-optimized CRT (LOT-CRT) shows promise in enhancing outcomes for patients even if the ideal lead placement isn't possible.
- In a study of 72 patients, those who received LOT-CRT had more significant improvements in heart function and symptoms compared to traditional biventricular CRT (Biv-CRT), especially for those with lower QLV ratios.
Objectives: Cardiac arrhythmias predict poor outcome after myocardial infarction (MI). We studied if arrhythmia monitoring with an insertable cardiac monitor (ICM) can improve treatment and outcome.
Design: BIO|GUARD-MI was a randomized, international open-label study with blinded outcome assessment.
Chronic kidney disease (CKD) implies increased comorbidity burden, disability, and mortality, becoming a significant public health problem worldwide, however, prevalence data are lacking in Hungary. We determined CKD prevalence, stage distribution, comorbidities using estimated glomerular filtration rate (eGFR), albuminuria, and international disease codes in a cohort of healthcare utilizing residents within the catchment area of the University of Pécs, in the County Baranya, Hungary, between 2011 and 2019 by database analysis. The number of laboratory-confirmed and diagnosis-coded CKD patients were compared.
View Article and Find Full Text PDFBackground: Coronavirus disease 2019 (COVID-19) had spread into a pandemic affecting healthcare providers worldwide. Heart failure patients with implanted cardiac devices require close follow-up in-spite of pandemic related healthcare restrictions.
Methods: Patients were retrospectively registered and clinical outcomes were compared of 61 remote monitored (RMG) versus 71 conventionally (in-office only) followed (CFG) cardiac device implanted, heart failure patients.
Introduction: The impact of remote monitoring (RM) on clinical outcomes in heart failure (HF) patients with cardiac resynchronisation therapy-defibrillator (CRT-D) implantation is controversial. This study sought to evaluate the performance of an RM follow-up protocol using modified criteria of the PARTNERS HF trial in comparison with a conventional follow-up scheme.
Material And Methods: We compared cardiovascular (CV) mortality (primary endpoint) and hospitalisation events for decompensated HF, and the number of ambulatory in-office visits (secondary endpoint) in CRT-D implanted patients with automatic RM utilising daily transmissions (RM group, = 45) and conventional follow-up (CFU group, = 43) in a single-centre observational study.